MetLife Investment Management’s Skye Bioscience SKYE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,796	Closed	-$38.4K	–	2920
2024 Q2	$38.4K	Buy	+4,796	New	+$38.4K	﹤0.01%	2802